Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3757-3766

  Kannian, Priya ^a   Yin, Han ^a   Doueiri, Rami ^a   Lairmore, Michael D ^a,b   Fernandez, Soledad ^b   Green, Patrick L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APH 2 GENE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL IMMORTALIZATION; CELL SPECIFICITY; CLONAL EXPANSION; CONTROLLED STUDY; HBZ GENE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REX GENE; TAX GENE; VIRAL TROPISM; VIRUS ENVELOPE; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSFORMATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAX; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; RABBITS; VIRAL TROPISM;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; ORYCTOLAGUS CUNICULUS;

EID: 84861325366     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06900-11     Document Type: Article

References (47)

1. Araujo A, Hall WW. 2004. Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 56: 10-19.
2. Arnold J, et al. 2006. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107: 3976-3982.
3. Bartman MT, et al. 2008. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood 112: 3995-4002.
4. Bartoe JT, et al. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 74: 1094-1100.
5. Cockerell GL, Rovank J, Green PL, Chen ISY. 1996. A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo. Blood 87: 1030-1035.
6. Gessain A, et al. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii: 407-410.
7. Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O. 2010. Current concepts regarding the HTLV-1 receptor complex. Retrovirology 7: 99.
8. Ghez D, et al. 2006. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80: 6844-6854.
9. Goon PK, et al. 2004. Human T cell lymphotropic virus type I (HTLVI)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J. Immunol. 172: 1735-1743.
10. Grassmann R, Aboud M, Jeang KT. 2005. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24: 5976-5985.
11. Halin M, et al. 2009. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 114: 2427-2438.
12. Hanon E, et al. 2000. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13: 657-664.
13. Hattori T, Uchiyama T, Toibana T, Takatsuki K, Uchino H. 1981. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood 58: 645-647.
14. Haynes RA, II, Phipps AJ, Yamamoto B, Green P, Lairmore MD. 2009. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection. Viral Immunol. 22: 397-405.
15. Hinuma Y, et al. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U. S. A. 78: 6476-6480.
16. Hiraragi H, et al. 2006. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J. Virol. 80: 3469-3476.
17. Jones KS, et al. 2006. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80: 8291-8302.
18. Kira J, et al. 1991. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy; a quantitative polymerase reaction study. Ann. Neurol. 29: 194-201.
19. Knight SC, Macatonia SE, Cruickshank K, Rudge P, Patterson S. 1993. Dendritic cells in HIV-1 and HTLV-1 infection. Adv. Exp. Med. Biol. 329: 545-549.
20. Koyanagi Y, et al. 1993. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196: 25-33.
21. Lairmore MD, Silverman L, Ratner L. 2005. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24: 6005-6015.
22. Lal RB, Owen SM, Rudolph DL, Dawaon C, Prince H. 1995. In vivo cellular tropism of human T-cell lymphotrophic virus type-II is not restricted to CD8+ cells. Virology 210: 441-447.
23. Li M, Green PL. 2007. Detection and quantitation of HTLV-1 and HTLV-2mRNAspecies by real-time RT-PCR. J. Virol. Methods 142: 159-168.
24. Li M, Kesic M, Yin H, Lianbo Y, Green P. 2009. Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J. Virol. 83: 3788-3797.
25. Macatonia SE, Cruickshank JK, Rudge P, Knight SC. 1992. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res. Hum. Retroviruses 8: 1699-1706.
26. Manel N, et al. 2003. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115: 449-459.
27. Manns A, et al. 1999. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J. Infect. Dis. 180: 1487-1493.
28. Murphy EL, et al. 2004. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J. Infect. Dis. 190: 504-510.
29. Nath MD, Ruscetti FW, Petrow-Sadowski C, Jones KS. 2003. Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood 101: 3085-3092.
30. Newbound GC, Andrews JM, O'Rourke JP, Brady JN, Lairmore MD. 1996. Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T-lymphocytes. J. Virol. 70: 2101-2106.
31. Orland JR, et al. 2003. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61: 1588-1594.
32. Osame M, et al. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i: 1031-1032.
33. Pinon JD, et al. 2003. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J. Virol. 77: 9922-9930.
34. Poiesz BJ, et al. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 77: 7415-7419.
35. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058-6068.
36. Rende F, et al. 2011. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNA. Blood 117: 4855-4859.
37. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64: 5682-5687.
38. Roucoux DF, Murphy EL. 2004. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 6: 144-154.
39. Suemori K, et al. 2009. HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J. Gen. Virol. 90: 1806-1811.
40. Valeri VW, et al. 2010. Requirement of the human T-cell leukemia virus p12 and p30 genes for infectivity of human dendritic cells and macaques but not rabbits. Blood 116: 3809-3817.
41. Wang T-G, Ye J, Lairmore M, Green PL. 2000. In vitro cellular tropism of human T-cell leukemia virus type 2. AIDS Res. Hum. Retroviruses 16: 1661-1668.
42. Xie L, Green PL. 2005. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2. J. Virol. 79: 14536-14545.
43. Yamamoto B, et al. 2008. Human T-cell leukemia virus type 2 posttranscriptional control protein p28 is required for viral infectivity and persistence in vivo. Retrovirology 5: 38.
44. Ye J, Silverman L, Lairmore MD, Green PL. 2003. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood 102: 3963-3969.
45. Ye J, Xie L, Green PL. 2003. Tax and overlapping Rex sequences do not confer the distinct transformation tropisms of HTLV-1 and HTLV-2. J. Virol. 77: 7728-7735.
46. Yoshida M, Miyoshi I, Hinuma Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U. S. A. 79: 2031-2035.
47. Zhi H, et al. 2011. NF-kappaB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ. PLoS Pathog. Vasanth12 7: e1002025.